Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organon
Biotech
Organon axes 'biggest potential opportunity' after trial fail
An endometriosis drug candidate Organon hailed as perhaps its “biggest potential opportunity” has flunked a phase 2 trial.
Nick Paul Taylor
Jul 2, 2025 8:43am
Organon to work with White House on women's health research: CEO
Nov 15, 2023 10:41am
Organon touts real-world win of its postpartum hemorrhage device
Sep 18, 2023 11:25am
Bayer deprioritizes women's health R&D
Mar 24, 2023 2:40pm
Organon builds pipeline for women's health but can't do it alone
Mar 16, 2023 11:12am
Organon places bet on hysterectomy hardware maker Claria Medical
Jan 9, 2023 9:50am
